Rodrigues GA, Shalaev E, Karami TK, Cunningham J, Slater NKH, Rivers HM. Pharmaceutical development of AAV-based gene therapy products for the eye. Pharm Res. 2018;36:29.

Article  PubMed  PubMed Central  Google Scholar 

Bougioukli S, Chateau M, Morales H, Vakhshori V, Sugiyama O, Oakes D, et al. Correction: limited potential of AAV-mediated gene therapy in transducing human mesenchymal stem cells for bone repair applications. Gene Ther. 2024;31:527.

Article  CAS  PubMed  Google Scholar 

Bulcha JT, Wang Y, Ma H, Tai PW, Gao G. Viral vector platforms within the gene therapy landscape. Signal Transduct Target Ther. 2021;6:53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yang T-y, Braun M, Lembke W, McBlane F, Kamerud J, DeWall S, et al. Immunogenicity assessment of AAV-based gene therapies: an IQ consortium industry white paper. Mol Ther-Methods Clin Dev. 2022;26:471–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hinderer C, Katz N, Buza EL, Dyer C, Goode T, Bell P, et al. Severe toxicity in nonhuman primates and piglets following high-dose intravenous administration of an adeno-associated virus vector expressing human SMN. Hum Gene Ther. 2018;29:285–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mingozzi F, High KA. Immune responses to AAV vectors: overcoming barriers to successful gene therapy. Blood. 2013;122:23–36.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Laforet GA. Thrombotic microangiopathy associated with systemic adeno-associated virus gene transfer: review of reported cases. Hum Gene Ther. 2025;36:64–76.

Article  CAS  PubMed  Google Scholar 

Davidoff AM, Gray JT, Ng CY, Zhang Y, Zhou J, Spence Y, et al. Comparison of the ability of adeno-associated viral vectors pseudotyped with serotype 2, 5, and 8 capsid proteins to mediate efficient transduction of the liver in murine and nonhuman primate models. Mol Ther. 2005;11:875–88.

Article  CAS  PubMed  Google Scholar 

Wang L, Calcedo R, Bell P, Lin J, Grant RL, Siegel DL, et al. Impact of pre-existing immunity on gene transfer to nonhuman primate liver with adeno-associated virus 8 vectors. Hum Gene Ther. 2011;22:1389–401.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Issa SS, Shaimardanova AA, Solovyeva VV, Rizvanov AA. Various AAV serotypes and their applications in gene therapy: an overview. Cells. 2023;12:785.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Naso MF, Tomkowicz B, Perry III, WL, Strohl WR. Adeno-associated virus (AAV) as a vector for gene therapy. BioDrugs. 2017;31:317–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rajavel K, Ayash-Rashkovsky M, Tang Y, Gangadharan B, de la Rosa M, Ewenstein B. Co-prevalence of pre-existing immunity to different serotypes of adeno-associated virus (AAV) in adults with hemophilia. Blood. 2019;134:3349.

Article  Google Scholar 

Boutin S, Monteilhet V, Veron P, Leborgne C, Benveniste O, Montus MF, et al. Prevalence of serum IgG and neutralizing factors against adeno-associated virus (AAV) types 1, 2, 5, 6, 8, and 9 in the healthy population: implications for gene therapy using AAV vectors. Hum Gene Ther. 2010;21:704–12.

Article  CAS  PubMed  Google Scholar 

Calcedo R, Wilson JM. Humoral immune response to AAV. Front Immunol. 2013;4:341.

Article  PubMed  PubMed Central  Google Scholar 

Nidetz NF, McGee MC, Tse LV, Li C, Cong L, Li Y, et al. Adeno-associated viral vector-mediated immune responses: understanding barriers to gene delivery. Pharm Ther. 2020;207:107453.

Article  CAS  Google Scholar 

Falese L, Sandza K, Yates B, Triffault S, Gangar S, Long B, et al. Strategy to detect pre-existing immunity to AAV gene therapy. Gene Ther. 2017;24:768–78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stanford S, Pink R, Creagh D, Clark A, Lowe G, Curry N, et al. Adenovirus-associated antibodies in UK cohort of hemophilia patients: a seroprevalence study of the presence of adenovirus-associated virus vector-serotypes AAV5 and AAV8 neutralizing activity and antibodies in patients with hemophilia A. Res Pr Thromb Haemost. 2019;3:261–7.

Article  CAS  Google Scholar 

Calcedo R, Morizono H, Wang L, McCarter R, He J, Jones D, et al. Adeno-associated virus antibody profiles in newborns, children, and adolescents. Clin Vaccin Immunol. 2011;18:1586–8.

Article  CAS  Google Scholar 

Chicoine LG, Montgomery C, Bremer W, Shontz K, Griffin D, Heller K, et al. Plasmapheresis eliminates the negative impact of AAV antibodies on microdystrophin gene expression following vascular delivery. Mol Ther. 2014;22:338–47.

Article  CAS  PubMed  Google Scholar 

Monteilhet V, Saheb S, Boutin S, Leborgne C, Veron P, Montus MF, et al. A 10 patient case report on the impact of plasmapheresis upon neutralizing factors against Adeno-associated Virus (AAV) Types 1, 2, 6, and 8. Mol Ther. 2011;19:2084–91.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ertl HCJ. Mitigating serious adverse events in gene therapy with AAV vectors: vector dose and immunosuppression. Drugs. 2023;83:287–98.

Article  CAS  PubMed  Google Scholar 

Esfandiari J. Dual path immunoassay device. US Patent. 2017;US9784734B2.

Pabinger I, Ayash-Rashkovsky M, Escobar M, Konkle BA, Mingot-Castellano ME, Mullins ES, et al. Multicenter assessment and longitudinal study of the prevalence of antibodies and related adaptive immune responses to AAV in adult males with hemophilia. Gene Ther. 2024;31:273–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boadella M, Lyashchenko K, Greenwald R, Esfandiari J, Jaroso R, Carta T, et al. Serologic tests for detecting antibodies against Mycobacterium bovis and Mycobacterium avium subspecies paratuberculosis in Eurasian wild boar (Sus scrofa scrofa). J Vet Diagnostic Investig. 2011;23:77–83.

Article  Google Scholar 

Kruzik A, Raim R, Voelkel D, Weiller M, Hoellriegl W, Scheiflinger F, et al. AAV8-specific immune adsorption column: a treatment option for patients with pre-existing anti-AAV8 neutralizing antibodies. Blood. 2019;134:5922.

Article  Google Scholar 

Clinical, Institute LS. CLSI document EP17‑A2, Evaluation of detection capability for clinical laboratory measurement procedures; approved guideline. Clinical and Laboratory Standards Institute Wayne, PA; 2nd edition 2012.

Armbruster DA, Pry T. Limit of blank, limit of detection and limit of quantitation. Clin Biochem Rev. 2008;29 Suppl 1:S49–52.

PubMed  Google Scholar 

Institute CaLS. CLSI EP25‑Ed2: Evaluation of Stability of In Vitro Medical Laboratory Test Reagents. 2nd edition 2023.

Mendell JR, Connolly AM, Lehman KJ, Griffin DA, Khan SZ, Dharia SD, et al. Testing preexisting antibodies prior to AAV gene transfer therapy: rationale, lessons and future considerations. Mol Ther-Methods Clin Dev. 2022;25:74–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gorovits B, Azadeh M, Buchlis G, Harrison T, Havert M, Jawa V, et al. Evaluation of the humoral response to adeno-associated virus-based gene therapy modalities using total antibody assays. AAPS J. 2021;23:1–17.

Article  Google Scholar 

Gorovits B, Fiscella M, Havert M, Koren E, Long B, Milton M, et al. Recommendations for the development of cell-based anti-viral vector neutralizing antibody assays. AAPS J. 2020;22:1–10.

Google Scholar 

Iregbu KC, Esfandiari J, Nnorom J, Sonibare SA, Uwaezuoke SN, Eze SO, et al. Dual path platform HIV 1/2 assay: evaluation of a novel rapid test using oral fluids for HIV screening at the National Hospital in Abuja, Nigeria. Diagnostic Microbiol Infect Dis. 2011;69:405–9.

Article  Google Scholar 

Nabity SA, Ribeiro GS, Lessa Aquino C, Takahashi D, Damião AO, Gonçalves AH, et al. Accuracy of a dual path platform (DPP) assay for the rapid point-of-care diagnosis of human leptospirosis. PLoS Neglected Trop Dis. 2012;6:e1878.

Article  Google Scholar 

Elkins S. Identification of Patient Specific Neutralizing Epitopes on the AAV8 Virus for Personalized Gene Therapy. Masters Thesis, Digital Access to Scholarship at Harvard: Harvard; 2020.

Nam HJ, Lane MD, Padron E, Gurda B, McKenna R, Kohlbrenner E, et al. Structure of adeno-associated virus serotype 8, a gene therapy vector. J Virol. 2007;81:12260–71.

Article  CAS  PubMed